India, SACU Revive Trade Pact Talks at BRICS with Focus on Pharma and Minerals

India and the Southern African Customs Union are advancing talks to revive the long-stalled India SACU PTA negotiations, with the India SACU trade agreement now positioned as a key vehicle for tariff reductions and deeper cooperation in pharmaceuticals and critical minerals. The renewed engagement, coordinated at recent BRICS meetings, underscores political will to boost commerce across the five SACU economies where South Africa dominates existing trade volumes.

Source: Ministry of Commerce & Industry, Government of India

India SACU Trade Agreement Gains Fresh Momentum

Senior officials from both sides have resumed technical exchanges to finalize terms of reference that will guide future tariff concessions. These steps build on earlier virtual rounds that set timelines for data sharing and addressed product sensitivities, including textiles and agricultural goods. The process now emphasizes draft modalities managed through the SACU secretariat, marking measurable progress after negotiations stalled following five rounds held between 2002 and 2010.

Ad

Trade Data and Sectoral Priorities

Bilateral merchandise trade rose from 11,505 million US dollars in 2020-21 to a peak of 19,246 million US dollars in 2023-24, though India continues to run a deficit driven largely by mineral imports. Indian shipments focus on vehicles, pharmaceuticals, and engineering products, while inflows center on gold, coal, and manganese ore. The India SACU trade agreement is expected to unlock preferential access for Indian pharmaceutical exports across the region, supporting regulatory alignment and lower tariff barriers that could improve medicine availability and pricing.

Supply-Chain Resilience Through Expanded Cooperation

Successful conclusion of the terms of reference would strengthen resilient supply chains for active pharmaceutical ingredients and generic medicines, aligning with global efforts to diversify sourcing away from single-country dependence. Namibia’s current role as SACU lead coordinator has helped maintain dialogue momentum into 2025. Analysts note that deeper integration under the India SACU trade agreement could also foster joint manufacturing ventures and technology transfers in the health sector, delivering long-term benefits for both Indian exporters and SACU member states seeking affordable, high-quality medicines.

The strategic focus on pharmaceuticals reflects broader economic goals while addressing practical healthcare needs in southern Africa. By reducing import duties on key drugs and intermediates, the framework may encourage Indian firms to expand market presence and invest in local regulatory compliance. Continued data exchanges on tariff lines will be essential to balance sensitivities on both sides and sustain the positive trajectory established at recent high-level meetings.